Drug News
The systemic safety of bevacizumab appears to be similar to that of ranibizumab as intravitreal therapy for neovascular age-related macular degeneration (AMD).
Drug News
Adjuvant bevacizumab increases overall survival in cervical cancer and improves progression-free survival in glioblastoma.
Drug News
No evidence of infection, inflammation when bevacizumab is stored at 4 Celsius for a week
Drug News
Both linked to improvements in visual acuity; only triamcinolone tied to sustained improvement in CMT
Drug News
Findings show benefits compared with FOLFIRI for patients with untreated metastatic disease.
Drug News
For patients with diabetic macular edema (DME), visual acuity (VA) improves over two years with treatment with different anti-vascular endothelial growth factor (VEGF) agents, according to a study published online in Ophthalmology.
Drug News
By switching preferred therapy for macular degeneration, Medicare can realize substantial cost savings.
Drug News
Dose-dense weekly paclitaxel does not improve progression-free survival in ovarian cancer, according to a study published in the New England Journal of Medicine.
Drug News
An experimental vaccine and a drug already on the market each may help slow down advanced ovarian cancer, two new studies suggest.
Drug News
For women with platinum-resistant ovarian cancer, the addition of Avastin (bevacizumab) to chemotherapy is associated with improved progression-free survival.
